tiprankstipranks
YAMASHITA HEALTH CARE HOLDINGS, INC. (JP:9265)
:9265
Japanese Market

YAMASHITA HEALTH CARE HOLDINGS, INC. (9265) AI Stock Analysis

0 Followers

Top Page

JP:9265

YAMASHITA HEALTH CARE HOLDINGS, INC.

(9265)

Select Model
Select Model
Select Model
Outperform 70 (OpenAI - 5.2)
Rating:70Outperform
Price Target:
¥4,033.00
▲(23.15% Upside)
Action:ReiteratedDate:12/30/25
The score is led by strong financial stability (notably zero debt) and improving revenue growth, supported by constructive technical trends (price above key moving averages and positive MACD). Offsetting factors are very thin margins and a recent deterioration in cash conversion, while valuation is reasonable but not especially cheap and the dividend is modest.
Positive Factors
Debt-free balance sheet
Zero reported debt provides durable financial flexibility, lowering insolvency risk and enabling the company to fund working capital, capex, or M&A from internal cash or modest equity without interest expense. This supports resilience across economic cycles and strategic optionality.
Negative Factors
Very thin net margins
A net margin around 1% leaves little buffer for cost increases or pricing pressure typical in medical distribution. This structurally limits retained earnings for reinvestment and heightens sensitivity to supply chain or labor cost shocks, constraining long-term profitability improvements.
Read all positive and negative factors
Positive Factors
Negative Factors
Debt-free balance sheet
Zero reported debt provides durable financial flexibility, lowering insolvency risk and enabling the company to fund working capital, capex, or M&A from internal cash or modest equity without interest expense. This supports resilience across economic cycles and strategic optionality.
Read all positive factors

YAMASHITA HEALTH CARE HOLDINGS, INC. (9265) vs. iShares MSCI Japan ETF (EWJ)

YAMASHITA HEALTH CARE HOLDINGS, INC. Business Overview & Revenue Model

Company Description
Yamashita Health Care Holdings,Inc. engages in the supply of medical equipment in Japan. The company offers diagnostic imaging devices, such as MRI and CT, endoscopic systems, operating tables, shadowless lights, and surgical equipment comprising ...
How the Company Makes Money
null...

YAMASHITA HEALTH CARE HOLDINGS, INC. Financial Statement Overview

Summary
Financial health is supported by a debt-free balance sheet and steadily rising equity. Revenue growth has improved (mid-single digits historically, ~12% most recently), but profitability remains thin (~1% net margin) and EBIT has not consistently expanded. Cash flow stays positive, yet cash conversion weakened sharply in the latest year (FCF ~55% of net income), adding some quality risk.
Income Statement
63
Positive
Balance Sheet
86
Very Positive
Cash Flow
57
Neutral
BreakdownTTMMay 2024May 2023May 2022May 2021May 2020
Income Statement
Total Revenue64.38B64.49B61.55B58.20B55.15B70.13B
Gross Profit8.72B8.57B8.30B7.86B7.52B7.33B
EBITDA922.00M1.06B1.18B1.36B1.15B1.17B
Net Income531.00M616.00M580.00M218.00M696.08M678.49M
Balance Sheet
Total Assets25.20B27.55B26.56B24.83B24.39B24.62B
Cash, Cash Equivalents and Short-Term Investments3.24B5.70B5.30B5.83B3.98B3.65B
Total Debt0.000.000.000.000.000.00
Total Liabilities16.25B18.56B18.00B16.90B16.38B17.04B
Stockholders Equity8.94B8.98B8.54B7.91B7.98B7.58B
Cash Flow
Free Cash Flow0.00338.00M804.00M2.12B473.94M765.29M
Operating Cash Flow0.00617.00M878.00M2.17B581.27M911.53M
Investing Cash Flow0.0019.00M-1.07B-107.00M-27.66M-134.14M
Financing Cash Flow0.00-240.00M-335.00M-209.00M-230.00M-137.81M

YAMASHITA HEALTH CARE HOLDINGS, INC. Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price3275.00
Price Trends
50DMA
3630.90
Negative
100DMA
3445.15
Positive
200DMA
3231.57
Positive
Market Momentum
MACD
-24.54
Positive
RSI
41.21
Neutral
STOCH
19.70
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9265, the sentiment is Neutral. The current price of 3275 is below the 20-day moving average (MA) of 3672.75, below the 50-day MA of 3630.90, and above the 200-day MA of 3231.57, indicating a neutral trend. The MACD of -24.54 indicates Positive momentum. The RSI at 41.21 is Neutral, neither overbought nor oversold. The STOCH value of 19.70 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:9265.

YAMASHITA HEALTH CARE HOLDINGS, INC. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
¥2.85B27.022.56%-3.06%-38.56%
72
Outperform
¥43.24B11.612.63%0.30%-31.28%
70
Outperform
¥9.04B14.831.87%2.65%8.83%
64
Neutral
¥12.86B10.683.90%3.64%-4.70%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
50
Neutral
¥18.74B14.561.83%4.30%52.38%
45
Neutral
¥6.29B-88.531.41%18.03%-11.68%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:9265
YAMASHITA HEALTH CARE HOLDINGS, INC.
3,540.00
944.17
36.37%
JP:2425
Care Service Co., Ltd.
751.00
41.38
5.83%
JP:2689
OLBA HEALTHCARE HOLDINGS, Inc.
2,113.00
252.57
13.58%
JP:3417
Ohki Health Care Holdings, Inc.
1,359.00
687.28
102.32%
JP:6062
Charm Care Corporation
1,326.00
231.21
21.12%
JP:7061
Japan Hospice Holdings Inc.
746.00
-501.74
-40.21%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 30, 2025